Since 1996, HEXACATH has headed a Research and Development program in collaboration with public laboratories, international clinicians and key opinion leaders, with the aim of putting together a range of advanced cardiovascular products. In the past 7 years huge investments have been made to develop a unique coating technology based on Titanium-Nitride-Oxide which has been patented.

Bio Active Coating does represent today a real alternative to both BMS (bare Metal Stents) and DES (Drug Eluting Stents) offering lower restenosis and thrombosis while patients have not to be under dual antiplatelet treatment for the long run.

The manufacturing plant located in France in the Doubs area is close to Geneva. This location is famous for its expertise in micromechanics and metal know-how since centuries and could be called the "European Silicon Valley". Hexacath has set up there its manufacturing facility as well as its Research and Development Department.

The Headquarters are located near Paris where the Commercial, Export, Quality and Regulatory Affairs Departments can be found.



HEXACATH is a registered ISO 9001 and EN 13485 company. All the HEXACATH products are CE marked.

The company has expanded its distribution network via distributors or direct organizations in more than 40 countries.



This website (www.hexacath.com) is operated by Hexacath company. It is intented for use by healthcare professionals except french healthcare professionals. This website aims at providing general information on the organization and activity of Hexacath.

Last update: 4th of october, 2012